Cargando…
Residual Complexity Does Impact Organic Chemistry and Drug Discovery: The Case of Rufomyazine and Rufomycin
[Image: see text] Residual complexity (RC) involves the impact of subtle but critical structural and biological features on drug lead validation, including unexplained effects related to unidentified impurities. RC commonly plagues drug discovery efforts due to the inherent imperfections of chromato...
Autores principales: | Choules, Mary P., Klein, Larry L., Lankin, David C., McAlpine, James B., Cho, Sang-Hyun, Cheng, Jinhua, Lee, Hanki, Suh, Joo-Won, Jaki, Birgit U., Franzblau, Scott G., Pauli, Guido F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006449/ https://www.ncbi.nlm.nih.gov/pubmed/29792329 http://dx.doi.org/10.1021/acs.joc.8b00988 |
Ejemplares similares
-
Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M. abscessus
por: Choules, Mary P., et al.
Publicado: (2019) -
Strategies in anti-Mycobacterium tuberculosis drug discovery based on phenotypic screening
por: Grzelak, Edyta M., et al.
Publicado: (2019) -
Rufomycin Exhibits Dual Effects Against Mycobacterium abscessus Infection by Inducing Host Defense and Antimicrobial Activities
por: Park, Cho Rong, et al.
Publicado: (2021) -
In vitro elucidation of the crucial but complex oxidative tailoring steps in rufomycin biosynthesis enables one pot conversion of rufomycin B to rufomycin C
por: Perez Ortiz, Gustavo, et al.
Publicado: (2021) -
Correction to Importance
of Purity Evaluation and
the Potential of Quantitative (1)H NMR as a Purity Assay
por: Pauli, Guido F., et al.
Publicado: (2015)